Leadership & Pay ·
Guardant Health grants Co-CEOs Helmy Eltoukhy and AmirAli Talasaz 465,413 PSUs each
GHGuardant Health, Inc.
The Board of Directors approved performance-based restricted stock unit awards for Co-CEOs Helmy Eltoukhy and AmirAli Talasaz. Each executive received a grant of 465,413 target shares tied to total shareholder return relative to the S&P 500 Index over three-year and five-year periods. The awards are designed to align compensation with long-term stockholder value creation and market-leading performance. Guardant Health operates in the healthcare industry, providing genomic testing services for cancer patients.